Search research articles
Contact Us
Filters
Showing results (131-140 of 294) with videos related to
Page
of 30
Sort By:
British Journal of Haematology
|
February 22, 2021
Phase I study of F16IL2 antibody-cytokine fusion with very low-dose araC in acute myeloid leukaemia relapse after allogeneic stem cell transplantation
Christoph Schliemann, Torsten Kessler, Andrew F Berdel, et al.
Blood Advances
|
June 3, 2026
Epcoritamab in Richter Transformation: Insights from a Real-World Case Series
Vanja Zeremski, Sina Alexandra Beer, Frederik Damm, et al.
Cancers
|
July 2, 2021
Targeting Tissue Factor to Tumor Vasculature to Induce Tumor Infarction
Andrew F Berdel, Christian Schwöppe, Caroline Brand, et al.
Leukemia & Lymphoma
|
March 29, 2021
Allogeneic hematopoietic stem cell transplantation for therapy-related myeloid neoplasms following treatment of a lymphoid malignancy
Daniela V Wenge, Klaus Wethmar, Jan-Henrik Mikesch, et al.
International Journal of Molecular Sciences
|
August 12, 2023
Complete Metabolic Response to Combined Immune Checkpoint Inhibition after Progression of Metastatic Colorectal Cancer on Pembrolizumab: A Case Report
Carolin Krekeler, Klaus Wethmar, Jan-Henrik Mikesch, et al.
Chemistry & Biology
|
January 6, 2015
Activity-based probes for detection of active MALT1 paracaspase in immune cells and lymphomas
Andrea C Eitelhuber, Oliver Vosyka, Daniel Nagel, et al.
Cancer Research
|
January 15, 2020
Lymphoma Angiogenesis Is Orchestrated by Noncanonical Signaling Pathways
Marleen Gloger, Lutz Menzel, Michael Grau, et al.
Haematologica
|
December 11, 2025
Rituximab, Dexamethasone, Etoposide, Ifosfamide and Carboplatin (R-DeVIC) in relapsed or refractory central nervous system lymphoma - a retrospective multicentre clinical study
Kudret Kama, Hannes Treiber, Alexandra Kutilina, et al.
Leukemia
|
September 25, 2024
Pola-R-CHP or R-CHOEP for first-line therapy of younger patients with high-risk diffuse large B-cell lymphoma: a retrospective comparison of two randomized phase 3 trials
Georg Lenz, Hervé Tilly, Marita Ziepert, et al.
Blood Advances
|
November 15, 2023
Deep learning predicts therapy-relevant genetics in acute myeloid leukemia from Pappenheim-stained bone marrow smears
Jacqueline Kockwelp, Sebastian Thiele, Jannis Bartsch, et al.
Page
of 30
Search research articles
Search
Showing results (131-140 of 294) with videos related to
Sort By:
Page
of 30
British Journal of Haematology
|
February 22, 2021
Phase I study of F16IL2 antibody-cytokine fusion with very low-dose araC in acute myeloid leukaemia relapse after allogeneic stem cell transplantation
Christoph Schliemann, Torsten Kessler, Andrew F Berdel, et al.
Blood Advances
|
June 3, 2026
Epcoritamab in Richter Transformation: Insights from a Real-World Case Series
Vanja Zeremski, Sina Alexandra Beer, Frederik Damm, et al.
Cancers
|
July 2, 2021
Targeting Tissue Factor to Tumor Vasculature to Induce Tumor Infarction
Andrew F Berdel, Christian Schwöppe, Caroline Brand, et al.
Leukemia & Lymphoma
|
March 29, 2021
Allogeneic hematopoietic stem cell transplantation for therapy-related myeloid neoplasms following treatment of a lymphoid malignancy
Daniela V Wenge, Klaus Wethmar, Jan-Henrik Mikesch, et al.
International Journal of Molecular Sciences
|
August 12, 2023
Complete Metabolic Response to Combined Immune Checkpoint Inhibition after Progression of Metastatic Colorectal Cancer on Pembrolizumab: A Case Report
Carolin Krekeler, Klaus Wethmar, Jan-Henrik Mikesch, et al.
Chemistry & Biology
|
January 6, 2015
Activity-based probes for detection of active MALT1 paracaspase in immune cells and lymphomas
Andrea C Eitelhuber, Oliver Vosyka, Daniel Nagel, et al.
Cancer Research
|
January 15, 2020
Lymphoma Angiogenesis Is Orchestrated by Noncanonical Signaling Pathways
Marleen Gloger, Lutz Menzel, Michael Grau, et al.
Haematologica
|
December 11, 2025
Rituximab, Dexamethasone, Etoposide, Ifosfamide and Carboplatin (R-DeVIC) in relapsed or refractory central nervous system lymphoma - a retrospective multicentre clinical study
Kudret Kama, Hannes Treiber, Alexandra Kutilina, et al.
Leukemia
|
September 25, 2024
Pola-R-CHP or R-CHOEP for first-line therapy of younger patients with high-risk diffuse large B-cell lymphoma: a retrospective comparison of two randomized phase 3 trials
Georg Lenz, Hervé Tilly, Marita Ziepert, et al.
Blood Advances
|
November 15, 2023
Deep learning predicts therapy-relevant genetics in acute myeloid leukemia from Pappenheim-stained bone marrow smears
Jacqueline Kockwelp, Sebastian Thiele, Jannis Bartsch, et al.
Page
of 30